Grown Rogue International (GRUSF) Other Non Operating Income (2010 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Other Non Operating Income of $165268.0 in Q1 2026, up 100.0% quarter-over-quarter from -$5714.4 billion in Q4 2025, and up 2009.36% on a YoY basis from $7835.0 in Q1 2025.
Grown Rogue International (GRUSF) Other Non Operating Income (2010 - 2026) Analysis & Trends
Grown Rogue International's Other Non Operating Income history runs 16 years deep, the most recent figure standing at $165268.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 2009.36% year-over-year to $165268.0; the TTM figure through Mar 2026 stood at -$5738.6 billion (down 143.45% YoY), while the FY2025 annual figure was $932730.0, down 14.48% from the prior year.
- Other Non Operating Income was $165268.0 for Q1 2026 at Grown Rogue International, up from -$5714.4 billion in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $13584.8 billion in Q4 2024 to a low of -$5714.4 billion in Q4 2025.
- Historically, Other Non Operating Income has averaged $497.8 billion across 5 years, with a median of $2337.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income soared 4031322761.13% in 2024, then slumped 142.06% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$13658.0 in 2022, then surged by 2567.28% to $336981.0 in 2023, then jumped by 4031322761.13% to $13584.8 billion in 2024, then plunged by 142.06% to -$5714.4 billion in 2025, then surged by 100.0% to $165268.0 in 2026.
- The last three Other Non Operating Income figures came in at $165268.0 (Q1 2026), -$5714.4 billion (Q4 2025), and -$24.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165,268.00 |
| Dec 31, 2025 | -5,714.40 Bn |
| Sep 30, 2025 | -24.24 Bn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 7,835.00 |
| Dec 31, 2024 | 13,584.79 Bn |
| Sep 30, 2024 | -378.59 Bn |
| Jun 30, 2024 | -7.55 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | 336,981.00 |
| Oct 31, 2023 | 217,713.00 |
| Jul 31, 2023 | 2,337.00 |
| Apr 30, 2023 | -270,712.00 |
| Jan 31, 2023 | 64,360.00 |
| Jan 31, 2022 | -13,658.00 |
| Oct 31, 2021 | 9,507.00 |
| Jul 31, 2021 | 53.00 |
| Apr 30, 2021 | 114,997.00 |
| Jan 31, 2021 | 319,627.00 |
| Oct 31, 2020 | -438,274.00 |